# Jiangsu Grand Xinyi Pharmaceutical Co., Ltd – FDA Inspection, Sep 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-grand-xinyi-pharmaceutical-co-ltd/d46c7117-3f8e-46d9-8c78-89000b921e72
Source feed: FDA_Inspections

> FDA inspection 1102870 of Jiangsu Grand Xinyi Pharmaceutical Co., Ltd, September 12, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102870
- Company Name: Jiangsu Grand Xinyi Pharmaceutical Co., Ltd
- Inspection Date: 2019-09-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)

Company: https://www.keypedia.com/companies/jiangsu-grand-xinyi-pharmaceutical-co-ltd/be4e990f-c96f-4c50-8571-a0357b036062

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c